GFRP Financials 07/16/2014 18:41:46 GFR Pharmaceu

GFRP Financials 07/16/2014 18:41:46
GFR Pharmaceuticals, Inc.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 4,272 4,674 4,362
Cost of Revenue 1,498 1,222 674
Gross Profit 2,773 3,452 3,687
Operating Expenses
Research and Development - - -
Sales, General and Admin. 786 681 802
Non-Recurring Items (86) (195) (301)
Other 280 237 220
Operating Income 1,793 2,730 2,967
Income From Continuing Operations
Add'l Income/Expense Items 2 2 2
Earnings Before Interest and Tax 1,795 2,732 3,224
Interest Expense - - -
Earnings Before Tax 1,795 2,732 3,224
Income Tax 460 674 688
Minority Interest 58 86 91
Equity Earnings Unconsolidated Subsidiary - - 256
Net Income Cont. Operations 1,277 1,971 2,702
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 1,277 1,971 2,446
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 1,277 1,971 2,446